Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

Higher Incidence of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Anti-Angiogenic Agents

(2009) Jeanny B. Aragon-Ching et al.   CANCER INVESTIGATION

Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates

(2009) Karim Fizazi et al.   JOURNAL OF CLINICAL ONCOLOGY

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

(2009) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE

Combination of Bisphosphonates and Antiangiogenic Factors Induces Osteonecrosis of the Jaw More Frequently than Bisphosphonates Alone

(2009) C. Christodoulou et al.   ONCOLOGY

Effect of bisphosphonates on pain and quality of life in patients with bone metastases

(2009) Luis Costa et al.   Nature clinical practice. Oncology

Bevacizumab-associated osteonecrosis of the jaw

(2008) S. Greuter et al.   ANNALS OF ONCOLOGY

Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy

(2008) A. Lipton et al.   CLINICAL CANCER RESEARCH

Spinal Cord Compression in Patients With Advanced Metastatic Cancer

(2008) Janet L. Abrahm et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer

(2008) Georgiana K. Ellis et al.   JOURNAL OF CLINICAL ONCOLOGY

Bisphosphonate nephrotoxicity

(2008) Mark A. Perazella et al.   KIDNEY INTERNATIONAL

Impact of skeletal complications on patients’ quality of life, mobility, and functional independence

(2008) Luis Costa et al.   SUPPORTIVE CARE IN CANCER